CCR4 and neoplasm: Our group has shown that the lymphocyte-rich GCs tend to be more frequently positive for CCR4, and found a novel role of CCR4 in tumor-induced immunosuppression [18], indicating various expression profiles of CCR4 in GC tissues and multifunctional roles of this molecule in GC progression.